Diagnostic applications of radiolabeled peptides in nuclear endocrinology

Quarterly Journal of Nuclear Medicine

Volumn 43, Issue 3, 1999, Pages 268-280

  Behr, T M ^a   Behe, M ^a   Becker, W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cholecystokinin (CCK); G protein coupled receptors; Gastrin; Octreotide; Radiolabeled regulatory peptides; Somatostatin; Vasoactive intestinal peptide (VIP)

Indexed keywords

BOMBESIN; CHOLECYSTOKININ; GONADORELIN; OCTREOTIDE; PENTAGASTRIN; PENTETATE INDIUM IN 111; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; REGULATOR PROTEIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADENOCARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CARCINOID; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; GASTROINTESTINAL CARCINOMA; HUMAN; INSULINOMA; ISOTOPE LABELING; LUNG SMALL CELL CANCER; NEUROENDOCRINE TUMOR; RADIODIAGNOSIS; THYROID CANCER; TUMOR DIAGNOSIS;

HUMANS; NEUROENDOCRINE TUMORS; PEPTIDES; RADIOPHARMACEUTICALS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, PEPTIDE; RECEPTORS, SOMATOSTATIN; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; SOMATOSTATIN;

EID: 0032707513     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)